AEHR Announces $6M Follow-On Sonoma Orders; Modest Size vs. Prior Record, Shipment Execution Still Key

What happened

Aehr Test Systems announced approximately $6 million in follow-on production orders from its lead hyperscale customer for package-level burn-in of its next-generation AI processor, including Sonoma systems, burn-in modules, sockets, and software enhancements. This order is for the customer's second AI processor program and is expected to ramp production in calendar 2027, aligning with the company's FY27 shipment timeline previously highlighted. However, the order size is a fraction of the $41 million production order announced in April 2026, and it does not by itself resolve the core question of converting record bookings into shipped revenue and improving margins. The latest DeepValue report noted that AEHR's Q2 FY26 revenue fell 44% YoY to $10.3M with a net loss of $3.2M, despite strong bookings, underscoring the lumpy, shipment-timing-dependent nature of the business. Management has stated that Sonoma system shipments from the upgraded contract manufacturing facility are expected to begin imminently, but until financial results show sequential revenue growth and margin improvement, the stock's valuation remains stretched relative to fundamentals.

Implication

The $6M order is positive in signaling continuity with the lead hyperscaler and a second program on Sonoma, but its size relative to the $41M order and $92M+ second-half bookings suggests it may be a routine add-on rather than a step-change in demand. Investors should not overweight this announcement; the key risk remains that purchase orders are cancellable and the company has yet to demonstrate consistent shipment cadence, as evidenced by the recent revenue decline despite record bookings. The report's WAIT rating and checkpoints for sequential revenue acceleration and customer concentration below 25% remain in force, and this order alone does not meet those criteria. If future quarters show Sonoma shipments ramping as promised and gross margin improving, the stock could sustain levels of $115-$135, but if shipments push out, the bear case of $85 becomes more likely. Until then, the stock is likely to remain volatile and driven more by order headlines than by fundamental per-share value creation, and investors should maintain discipline around entry points near $80 or after shipment proof emerges.

Thesis delta

The original thesis was WAIT at $115.3, premised on the need to see shipment-driven revenue acceleration in FY27 and margin recovery before underwriting the valuation. This $6M follow-on order is a minor positive that demonstrates continued customer engagement but does not change the core uncertainty around conversion of bookings to revenue. The thesis remains unchanged: wait for shipment and margin proof; no adjustment to rating or price targets.